Biblio Discovery — Demo Discovery Service

5 results for "Mathieu Ferrari"

Showing 1–5 · 1.00 seconds · RSS

  1. Journal Article

    Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry

    Pedro Horna; Matthew J. Weybright; Mathieu Ferrari et al.

    Blood Cancer Journal, Vol. 14 No. 1 · 2024 · English · DOAJ Scopus

    Abstract The diagnosis of leukemic T-cell malignancies is often challenging, due to overlapping features with reactive T-cells and limitations of currently available T-cell clonality assays. Recently developed therapeutic antibodies specific for the mutually exclusive T-cell receptor constant β…

  2. Journal Article

    Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2

    Julia Taylor; Anna Bulek; Isaac Gannon et al.

    Frontiers in Immunology, Vol. 14 · 2023 · English · DOAJ Scopus

    SHP1 and SHP2 are SH2 domain-containing proteins which have inhibitory phosphatase activity when recruited to phosphorylated ITIMs and ITSMs on inhibitory immune receptors. Consequently, SHP1 and SHP2 are key proteins in the transmission of inhibitory signals within T cells, constituting an…

  3. Journal Article

    Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy

    Simon Thomas; Julia Taylor; Manuel Rodriguez-Justo et al.

    Journal for ImmunoTherapy of Cancer, Vol. 11 No. 6 · 2023 · English · DOAJ Scopus

    Background We used a proliferating ligand (APRIL) to construct a ligand-based third generation chimeric antigen receptor (CAR) able to target two myeloma antigens, B-cell maturation antigen (BCMA) and transmembrane activator and CAML interactor.Methods The APRIL CAR was evaluated in a Phase 1…

  4. Journal Article

    Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies

    Mathieu Ferrari; Matteo Righi; Vania Baldan et al.

    Nature Communications, Vol. 15 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Peripheral T cell lymphomas are typically aggressive with a poor prognosis. Unlike other hematologic malignancies, the lack of target antigens to discriminate healthy from malignant cells limits the efficacy of immunotherapeutic approaches. The T cell receptor expresses one of two highly…